603v16n04 90399541mmc1

Supplementary appendix
This appendix formed part of the original submission and has been peer reviewed.
We post it as supplied by the authors.
Supplement to: Weber JS, D’Angelo SP, Minor D, et al. Nivolumab versus chemotherapy
in patients with advanced melanoma who progressed after anti-CTLA-4 treatment
(CheckMate 037): a randomised, controlled, open-label, phase 3 trial. Lancet Oncol 2015;
published online March 18. http://dx.doi.org/10.1016/S1470-2045(15)70076-8.
ONLINE SUPPLEMENTARY MATERIALS
A randomised, controlled, open-label, phase 3 trial of nivolumab versus chemotherapy in patients with advanced
melanoma who progressed after anti-CTLA-4 therapy (CheckMate 037)
Jeffrey S. Weber,1 Sandra P. D’Angelo,2 David Minor,3 F. Stephen Hodi,4 Ralf Gutzmer,5 Bart Neyns,6 Christoph Hoeller,7
Nikhil I. Khushalani,8 Wilson H. Miller, Jr.,9 Christopher D. Lao,10 Gerald Linette,11 Luc Thomas,12 Paul Lorigan,13 Kenneth
F. Grossmann,14 Jessica C. Hassel,15 Michele Maio,16 Mario Sznol,17 Paolo A. Ascierto,18 Peter Mohr,19 Bartosz
Chmielowski,20 Alan Bryce,21 Inge M. Svane,22 Jean-Jacques Grob,23 Angela M. Krackhardt,24 Christine Horak,25 Alexandre
Lambert,26 Arvin S. Yang,25 James Larkin27
1
Moffitt Cancer Center, Tampa, FL, USA; 2Memorial Sloan-Kettering Cancer Center and Weill Cornell Medical College,
New York, NY, USA; 3California Pacific Center for Melanoma Research, San Francisco, CA, USA; 4Dana-Farber Cancer
Institute, Boston, MA, USA; 5Medizinische Hochschule Hannover, Hannover, Germany; 6Universitair Ziekenhuis Brussel,
Brussels, Belgium; 7Medical University of Vienna, Vienna, Austria; 8Roswell Park Cancer Institute, Buffalo, NY, USA;
9
Segal Cancer Centre, Jewish General Hospital, McGill University, Montreal, QC Canada; 10University of Michigan, Ann
Arbor, MI, USA; 11Washington University, St. Louis, MO, USA; 12Centre Hospitalier Universitaire de Lyon, Lyon, France;
13
Christie Hospital, Manchester, UK; 14Huntsman Cancer Institute, Salt Lake City, UT, USA; 15German Cancer Research
Centre University Hospital Heidelberg, Germany; 16Medical Oncology and Immunotherapy, University Hospital of Siena,
Istituto Toscano Tumori, Siena, Italy; 17Yale Cancer Center, New Haven, CT, USA; 18Istituto Nazionale Tumori Fondazione
G. Pascale, Naples, Italy; 19Elbe Kliniken Buxtehude, Buxtehude, Germany; 20Department of Medicine, UCLA, Los Angeles,
CA, USA; 21Department of Medicine, Mayo Clinic, Scottsdale, Arizona, USA, 22Department of Oncology, Herlev Hospital,
Copenhagen, Denmark; 23Aix-Marseille University, Hopital de la Timone, Marseille, France; 24TUM School of Medicine, III.
Medical Department, Munich, Germany; 25Bristol-Myers Squibb, Princeton, NJ, USA; 26Bristol-Myers Squibb, Braine-
I’Alleud, Belgium; 27Royal Marsden Hospital, London, UK
Table S1: Treatment-related select AEs of potential immune-related aetiology reported in ≥ 1% of patients
Nivolumab ICC
Select AE (organ category) (N=268) (N=102)
Any grade, n (%) Grade 3–4, n (%) Any grade, n (%) Grade 3–4, n (%)
Skin 78 (29·1) 1 (0·4) 12 (11·8) 0 (0)
Pruritus 43 (16·0) 0 (0) 2 (2·0) 0 (0)
Rash 25 (9·3) 1 (0·4) 5 (4·9) 0 (0)
Rash maculo-papular 14 (5·2) 0 (0) 2 (2·0) 0 (0)
Vitiligo 14 (5·2) 0 (0) 0 (0) 0 (0)
Dermatitis 5 (1·9) 0 (0) 0 (0) 0 (0)
Rash erythematous 3 (1·1) 0 (0) 0 (0) 0 (0)
Gastrointestinal 31 (11·6) 3 (1·1) 15 (14·7) 2 (2·0)
Diarrhea 30 (11·2) 1 (0·4) 15 (14·7) 2 (2·0)
Colitis 3 (1·1) 2 (0·7) 0 (0) 0 (0)
Endocrine 21 (7·8) 0 (0) 1 (1·0) 0 (0)
Hypothyroidism 15 (5·6) 0 (0) 0 (0) 0 (0)
Hyperthyroidism 5 (1·9) 0 (0) 1 (1·0) 0 (0)
Blood TSH increased 3 (1·1) 0 (0) 0 (0) 0 (0)
Hepatic 12 (4·5) 2 (0·7) 6 (5·9) 0 (0)
AST increased 11 (4·1) 1 (0·4) 2 (2·0) 0 (0)
ALT increased 7 (2·6) 2 (0·7) 1 (1·0) 0 (0)
Pulmonary 6 (2·2) 0 (0) 0 (0) 0 (0)
Pneumonitis 5 (1·9) 0 (0) 0 (0) 0 (0)
Renal 4 (1·5) 1 (0·4) 1 (1·0) 0 (0)
Blood creatine increase 2 (0·7) 0 (0) 0 (0) 0 (0)
Hypersensitivity/infusion reaction 5 (1·9) 1 (0·4) 8 (7·8) 0 (0)
Infusion-related reaction 3 (1·1) 1 (0·4) 7 (6·9) 0 (0)
AE=adverse event. ALT=alanine aminotransferase. AST=aspertate aminotransferase. ICC= investigator’s choice chemotherapy. TSH=thyroid stimulating hormone.
Table S2: ORR by chemotherapy received
Nivolumab Dacarbazine Paclitaxel/Carboplatin
(n=120) (n=19) (n=28)
ORR,* n (%), [95% CI] 38 (31·7) [23·5–40·8] 0 (0) [0·0–17·6] 5 (17·9) [6·1–36·9]
BOR,* n (%)
Complete response 4 (3·3) 0 (0) 0 (0)
Partial response 34 (28·3) 0 (0) 5 (17·9)
Stable disease 28 (23·3) 6 (31·6) 10 (35·7)
Progressive disease 42 (35·0) 8 (42·1) 7 (25·0)
Unable to determine† 12 (10·0) 5 (26·3) 6 (21·4)
ORR difference to nivolumab group,

31·7 (13·2–40·4) 13·8 (-5·5–27·1)
% (95% CI)
* †
Confirmed response by independent radiology review committee per RECIST v1.1. Patients who did not have a protocol specified scan at 9 month, due to most commonly clinical progression,
consent withdrawal, or receiving subsequent therapy. BOR=best overall response. CI=confidence interval. ORR=objective response rate. RECIST=Response Evaluation Criteria In Solid Tumours.
Table S3: Adverse events (reported in ≥10% of treated patients) by chemotherapy received
Dacarbazine (N=45)* Paclitaxel/Carboplatin (N=57)*
AE term
Any grade Grade 3–4 Grade 5 Any grade Grade 3–4 Grade 5
Total patients with an event, n (%) 34 (75.6) 11 (24.4) 0 47 (82.5) 21 (36.8) 0
Alopecia 1 (2.2) 0 0 27 (47.4) 0 0
Nausea 15 (33.3) 1 (2.2) 0 23 (40.4) 1 (1.8) 0
Fatigue 14 (31.1) 0 0 21 (36.8) 4 (7.0) 0
Anemia 6 (13.3) 1 (2.2) 0 17 (29.8) 4 (7.0) 0
Neutropenia 6 (13.3) 3 (6.7) 0 13 (22.8) 11 (19.3) 0
Decreased appetite 10 (22.2) 0 0 6 (10.5) 0 0
Vomiting 9 (20.0) 1 (2.2) 0 11 (19.3) 1 (1.8) 0
Diarrhea 4 (8.9) 1 (2.2) 0 11 (19.3) 1 (1.8) 0
Arthralgia 1 (2.2) 0 0 11 (19.3) 1 (1.8) 0
Constipation 4 (8.9) 0 0 10 (17.5) 1 (1.8) 0
Thrombocytopenia 1 (2.2) 1 (2.2) 0 9 (15.8) 5 (8.8) 0
Peripheral neuropathy 0 0 0 9 (15.8) 1 (1.8) 0
Paraesthesia 0 0 0 9 (15.8) 0 0
Myalgia 0 0 0 7 (12.3) 0 0
WBC count decreased 2 (4.4) 0 0 6 (10.5) 1 (1.8) 0

*
Safety analysis included all treated patients. AEs=adverse events. ICC=investigator’s choice chemotherapy. WBC=white blood cell.
Figure S1: Study design
Figure S2: PFS per IRC in the intention-to-treat ORR analysis population
Full List of Inclusion and Exclusion Criteria
Inclusion Criteria
1) Signed Written Informed Consent
a) Subjects must have signed and dated an IRB/IEC approved written informed consent form in accordance with regulatory
and institutional guidelines. This must be obtained before the performance of any protocol related procedures that are not
part of normal subject care.
b) Subjects must be willing and able to comply with scheduled visits, treatment schedule, laboratory tests and other
requirements of the study.
2) Target Population
a) Eastern Cooperative Oncology Group (ECOG) performance status of 1 (Refer to Appendix 2).
b) Histologically confirmed Stage III (unresectable) or Stage IV melanoma.
c) Measurable disease by CT or MRI per RECIST 1.1 criteria.
d) A pre-treatment recent core, excision or punch biopsy must be provided for PD-L1 status determination prior to
randomization and for exploratory biomarker analyses. The biopsy must be from an unresectable or metastatic site, and the
subject must have had no intervening systemic therapy between the time of biopsy and randomization. In order to be
randomized, a subject must be classified as PD-L1 positive, PD-L1 negative or PD-L1 indeterminate. If an insufficient
amount of recently acquired tumor tissue from an unresectable or metastatic site is available prior to the start of the
screening phase, subjects must consent to allow the acquisition of tumor biopsy by study personnel for performance of
biomarker analyses.
e) Subjects must consent to allow the acquisition of existing formalin-fixed paraffin-embedded (FFPE) material (“archival”)
(block or a minimum of 10 unstained slides) if available, for performance of correlative studies.
f) Subjects must have objective evidence of disease progression (eg, clinical or radiological) during or after at least 1(V600
wildtype) or at least 2 (V600 mutation positive) prior treatment regimens for advanced melanoma.
1. Subjects BRAF wildtype:
a) Must have objective evidence of progression of disease (PD) post (during or following) treatment with anti-
CTLA-4 containing therapy for advanced melanoma.
AND
b) In addition to progression post anti-CTLA-4 therapy, subjects that have received another treatment regimen
must have objective evidence of progression of disease (PD) during or following at least 1 cycle of
treatment for advanced melanoma.
2. Subjects BRAF V600 mutation positive:
a) Must have objective evidence of progression of disease (PD) post treatment with anti-CTLA-4 containing
therapy for advanced melanoma.
AND
b) In addition to progressing post anti-CTLA-4 therapy, subjects must have objective evidence of progression of
disease (PD) post treatment with a BRAF inhibitor.
c) Subjects may have received prior anti-CTLA-4 therapy and a BRAF inhibitor in any sequence or in
combination.
g) Prior chemotherapy or immunotherapy (tumor vaccine, cytokine, or growth factor given to control the cancer) must have
been completed at least 4 weeks before study drug administration, and all adverse events have either returned to baseline or
stabilized.
h) Prior anti-CTLA-4 therapy must have been completed at least 6 weeks before study drug administration.
i) Prior radiotherapy must have been completed at least 2 weeks prior to study drug administration.
j) Screening laboratory values must meet the following criteria and should be obtained within 14 days prior to randomization:
3) Age and Reproductive Status

a) Men and women aged 18 years of age.
b) Women of childbearing potential (WOCBP) must use method(s) of contraception based on the tables in Appendix 1.
Dacarbazine, carboplatin and paclitaxel are teratogenic. There is an insufficient amount of information to assess
teratogenicity for BMS-936558 (nivolumab). For a teratogenic study drug and/or when there is insufficient information to
assess teratogenicity (preclinical studies have not been done), a highly effective method(s) of contraception (failure rate of
less than 1% per year) is required. The individual methods of contraception and duration should be determined in
consultation with the investigator. WOCBP must follow instructions for birth control when the half life of the
investigational drug is greater than 24 hours, contraception should be continued for a period of 30 days plus the time
required for the investigational drug to undergo five half lives. The half-life of BMS-936558 (nivolumab) is up to 25 days;
therefore, WOCBP who received BMS-936558 (nivolumab) should use an adequate method to avoid pregnancy for 23
weeks after the last dose of BMS-936558 (nivolumab). WOCBP must follow instructions for birth control when the half
life of the investigational drug is less than 24 hours, contraception should be continued for a period of 30 days after the last
dose of investigational product. The half-life of dacarbazine and carboplatin is less than 24 hours, therefore WOCBP who
received either dacarbazine or carboplatin should use an adequate method to avoid pregnancy for 30 days after the last dose
of either dacarbazine or carboplatin. The paclitaxel product label requires WOCBP to use an effective method of
contraception for at least 6 months after the last dose of paclitaxel.
c) WOCBP must have a negative serum or urine pregnancy test (minimum sensitivity 25 IU/L or equivalent units of
HCG) within 24 hours prior to the start of investigational product.
d) Women must not be breastfeeding
e) Men who are sexually active with WOCBP must use any contraceptive method with a failure rate of less than 1% per year
(See Appendix 1). The investigator shall review contraception methods and the time period that contraception must be
followed. Men that are sexually active with WOCBP must follow instructions for birth control when the half life of the
investigational drug is greater than 24 hours, contraception should be continued for a period of 90 days plus the time
required for the investigational drug to undergo five half lives. The half-life of BMS-936558 (nivolumab) is up to 25 days;
therefore, men who received BMS-936558 (nivolumab) and are sexually active with WOCBP must continue contraception
for 31 weeks after the last dose of BMS-936558 (nivolumab). The half-life of dacarbazine, carboplatin and paclitaxel is
less than 24 hours. However, the dacarbazine and paclitaxel product labels require men who received dacarbazine or
paclitaxel and are sexually active with WOCBP to use an effective method of contraception for at least 6 months after the
last dose of dacarbazine or paclitaxel.
Exclusion Criteria
1) Target Disease Exceptions
a) Active brain metastasis or leptomeningeal metastasis. Subjects with brain metastases are eligible if these have been treated,
and must be without MRI (except where contraindicated in which case CT scan is acceptable) evidence of progression for
at least 8 weeks and not require immunosuppressive doses of systemic corticosteroids (> 10 mg/day prednisone or
equivalent) for at least 2 weeks prior to study drug administration.
b) Ocular melanoma.
c) Subjects whose melanoma is BRAF status unknown.
2) Medical History and Concurrent Diseases
a) Any treatment in a BMS-936558 (nivolumab) trial.
b) Prior systemic melanoma therapy with both dacarbazine and carboplatin and paclitaxel. Prior systemic therapy with one of
the treatments is permitted.
c) Any serious or uncontrolled medical disorder or active infection that, in the opinion of the investigator, may increase the
risk associated with study participation, study drug administration, or would impair the ability of the subject to receive
protocol therapy.
d) Subjects with previous malignancies (except non-melanoma skin cancers, in situ bladder cancer, gastric or colon cancers,
cervical cancers/dysplasia, or breast carcinoma in situ) are excluded unless a complete remission was achieved at least 2
years prior to study entry and no additional therapy is required or anticipated to be required during the study period.
e) Subjects with active, known or suspected autoimmune disease. Subjects with vitiligo, type I diabetes mellitus, residual
hypothyroidism due to autoimmune condition only requiring hormone replacement, psoriasis not requiring systemic
treatment, or conditions not expected to recur in the absence of an external trigger are permitted to enroll.
f) Subjects with a condition requiring systemic treatment with either corticosteroids (> 10 mg daily prednisone
equivalent) or other immunosuppressive medications within 14 days of study drug administration. Inhaled or topical
steroids, and adrenal replacement steroid doses > 10 mg daily prednisone equivalent, are permitted in the absence of active
autoimmune disease.
g) Subjects who received prior therapy with an anti-PD-1, anti-PD-L1 or anti-PD-L2, (or any other antibody or drug
specifically targeting T-cell co-stimulation or checkpoint pathways except for anti-CTLA-4 therapy as described above).
h) Known drug or alcohol abuse.
i) Yellow fever vaccine, live attenuated vaccines, or prophylactic phenytoin within 28 days prior to the first dose of study
drug.
3) Physical and Laboratory Test Findings
a) Any positive test for hepatitis B virus or hepatitis C virus indicating acute or chronic infection.
b) Known history of testing positive for human immunodeficiency virus (HIV) or known acquired immunodeficiency
syndrome (AIDS).
4) Allergies and Adverse Drug Reaction
a) Subjects with a known history of the following anti-CTLA-4 therapy related adverse reactions based on the CTCAE v4.0
criteria:
i) Grade 4 anti-CTLA-4 therapy related adverse reaction except resolved nausea, fatigue, infusion reactions or
endocrinopathies where clinical symptoms were able to be controlled with appropriate hormone replacement therapy.
Grade 3 anti-CTLA-4 therapy related adverse reactions must have resolved or been controlled within 12 weeks.
ii) Any ≥ Grade 2 eye pain or reduction of visual acuity that did not respond to topical therapy and did not improve to ≤
Grade 1 severity within 2 weeks of starting topical therapy or required systemic treatment.
iii) Any ≥ Grade 3 sensory neurologic toxicity.
iv) Any Grade 4 laboratory abnormalities, except AST, ALT or T. bilirubin;
(1) AST or ALT > 10 x ULN
(2) T. bilirubin > 5 x ULN
v) Subjects who required infliximab or other immune suppressants including mycophenolic acid for management of drug
related toxicities.
b) History of Grade ≥ 3 neurologic toxicity.
c) History of Grade ≥ 3 allergy to study drug components.
5) Sex and Reproductive Status
a) WOCBP who are pregnant or breastfeeding.
b) Women with a positive pregnancy test at enrollment or prior to administration of study medication.
6) Other Exclusion Criteria
a) Prisoners or subjects who are involuntarily incarcerated.
b) Subjects who are compulsorily detained for treatment of either a psychiatric or physical (eg, infectious disease) illness.
c) Current participation in another clinical study involving treatment with medications, radiation or surgery.
Eligibility criteria for this study have been carefully considered to ensure the safety of the study subjects and that the results of the
study can be used. It is imperative that subjects fully meet all eligibility criteria.
Women of Childbearing Potential

A Woman of Childbearing Potential (WOCBP) is defined as any female who has experienced menarche and who has not undergone
surgical sterilization (hysterectomy or bilateral oophorectomy) or is not postmenopausal. Menopause is defined clinically as 12
months of amenorrhea in a woman over age 45 in the absence of other biological or physiological causes. In addition, women under
the age of 62 must have a documented serum follicle stimulating hormone, (FSH) level > 40mIU/mL.
Treatment Guidelines for Immune-Related Select Adverse Events
List of Trial Sites and Investigators
Interim Clinical Study Report CA209037
BMS-936558 Nivolumab
Appendix 1.5 List and Description of Investigators for Study CA209-037

Site # Principal Investigator/ Sub Investigators and Responsible Study Center and Address # of Patients
Medical Personnel Enrolled
CA209-037-0001* Baurain, Jean-Francois, MD, PhD Cliniques Universitaires Saint-Luc 8
(Office)
Cornelis, Frank, MD, PhD Avenue Hippocrate 10
Danse, Etienne, MD, PhD Bruxelles, 1200
Duhoux, Francois, MD, PhD Belgium
Gizzi, Marco, MD
Humblet, Yves, MD, PhD Cliniques Universitaires Saint-Luc
Machiels, Jean-Pascal, MD, PhD Service D'oncologie
Mailleux, Marie, MD (Pt Tx Ctr - Med Office/Clinic)
Mardjuadi, Feby, MD Avenue Hippocrate, 10
Mazzeo, Filomena, MD, PhD Bruxelles, 1200
Taylor, Donatienne, MD Belgium
Van Den Eynde, Marc, MD
(P) +3227641111
(F) +3227641620
Email: jf.baurain@uclouvain.be
CA209-037-0002* Neyns, Bart, MD, PhD Universitair Ziekenhuis Brussel 18
Medische Oncologie
Boulet, Cedric, MD (Office)
De Greve, Jacques, MD, PhD Laarbeeklaan 101
Jansen, Yanina Brussels, 1090
Schreuer, Max, MD Belgium
Wilgenhof, Sofie, MD, PhD
Universitair Ziekenhuis Brussel
Medische Oncologie
(P) +3224776045 (Pt Tx Ctr - Hosp/Med Ctr)
(F) +3224775460 Laarbeeklaan 101
Brussels, 1090
Belgium
Email: bart.neyns@uzbrussel.be
9888
Approved v 1.0 930081508 1.0
CA209-037-0003* Schoffski, Patrick, MD, PhD Uz Leuven (Office) 5
Herestraat 49
Bechter, Olivier, MD Leuven, 3000
Beuselinck, Benoit, MD, PhD Belgium
Clement, Paul, MD, PhD
Dumez, Herlinde, MD Uz Leuven (Pt Tx Ctr - Hosp/Med Ctr)
Paridaens, Robert, MD, PhD Interne Geneeskunde - Algemene
Wildiers, Hans, MD, PhD Medische Oncologie
Wolter, Pascal, MD Herestraat 49
Leuven, 3000
Belgium
(P) +3216345506
(F) +3216343209
Email: patrick.schoffski@uzleuven.be
CA209-037-0005* Hospers, G. A. P, MD Universitair Medisch Centrum 5

Groningen (Office)
Schroder, Carolina, MD, PhD Hanzeplein 1
Van Den Brom, Rob Rh, MD, PhD Groningen, 9713 GZ
Netherlands
(P) +31503616161 Universitair Medisch Centrum

(F) +31503619320 Groningen (Pt Tx Ctr - Hosp/Med Ctr)
Hanzeplein 1
Groningen, 9713 GZ
Email: g.a.p.hospers@umcg.nl Netherlands
9889
Approved v 1.0 930081508 1.0
CA209-037-0006* Specenier, Pol, MD Universitair Ziekenhuis Antwerpen 2
(Office)
Altintas, Sevilay, MD, PhD Wilrijkstraat 10
Huizing, Manon Thirza, MD Edegem, 2650
Op De Beeck, Bart, MD Belgium
Papadimitriou, Konstantinos, MD
Peeters, Marc, MD, PhD Universitair Ziekenhuis Antwerpen
Rolfo, Christian, MD, PhD (Pt Tx Ctr - Hosp/Med Ctr)
Van Den Brande, Jan, MD Wilrijkstraat 10
Edegem, 2650
(P) +3238215466 Belgium
(F) +3238214488
Email: pol.specenier@uza.be
CA209-037-0007* Haanen, John, PhD Antoni Van Leeuwenhoek Ziekenhuis 5

(Office)
Blank, Christian, MD Plesmanlaan 121
Van Thienen, Hans, MD, PhD Amsterdam, 1066 CX
Netherlands
(P) +31205122569 Antoni Van Leeuwenhoek Ziekenhuis

(F) +31205122572 (Pt Tx Ctr - Hosp/Med Ctr)
Plesmanlaan 121
Afdeling Medische Oncologie
Email: j.haanen@nki.nl Amsterdam, 1066 CX
Netherlands
9890
Approved v 1.0 930081508 1.0
CA209-037-0008* Ottensmeier, Christian, MD, PhD Southampton University Hospital NHS 6
Trust (Office)
Bradbury, Jennifer, MBChB, MRCP Tremona Road
Chau, Caroline Shuet Yiu, MRCP Southampton, Hampshire, SO16 6YD
Wheater, Matthew, MD United Kingdom
(P) +442380796164 Southampton University Hospital NHS

(F) +442380794313 Trust (Pt Tx Ctr - Hosp/Med Ctr)
Southampton University Hospital
Email: cho@soton.ac.uk Tremona Road
Southampton, Hampshire, SO16 6YD
United Kingdom
CA209-037-0009* Lorigan, Paul, MD The Christie NHS Foundation Trust 13

(Office)
Fusi, Alberto, MD Wilmslow Road
Hodgetts, Jackie Manchester, M20 4BX
Howell, Matthew United Kingdom
(P) +01614463000 The Christie NHS Foundation Trust

(F) +01614463317 (Pt Tx Ctr - Med Office/Clinic)
Wilmslow Road
Email: paul.lorigan@christie.nhs.uk Manchester, M20 4BX
United Kingdom
9891
Approved v 1.0 930081508 1.0
CA209-037-0010* Larkin, James, MD The Royal Marsden Hospital 43
Medical Oncology (Office)
Georgios Antoniou, MD 203 Fulham Road
Biondo, Andrea, MD London, SW3 6JJ
Boafo-Yirenkyi, Melanie, MD United Kingdom
Davidson, Michael Edward, MBBS
Fisher, Rosalie, MDChB The Royal Marsden Hospital
Furness, Andrew, MD Medical Oncology
Georgiou, Alexandros (Pt Tx Ctr - Hosp/Med Ctr)
Gore, Martin, PhD 203 Fulham Road
Hewish, Madeleine, MD London, SW3 6JJ
Joshi, Kroopa, MD United Kingdom
Lee, Alexander
Letsa, Ioanna, GP
Lima, Joao
Lote, Hazel, MD
Macklin-Doherty, Aislinn
Martin, Juan
McCulloh, Gemma
Ng-Cheng-Hin, Brian
Okines, Alicia, MD
Seifert, Heike, MD
Stares, Mark, MBBS
Yousaf, Nadia
(P) +442078082123
(F) +442073512477
Email: james.larkin@rmh.nhs.uk
9892
Approved v 1.0 930081508 1.0
CA209-037-0011* Plummer, Elizabeth, MD Freeman Hospital 5

(Office)
Coyle, Vicky, MD Sir Bobby Robson Cancer Research &
Cresti, Nicola, MD Trials Centre
Haney, Sophie, MD The Northern Centre For Cancer Care
Haris, Noor, MBBS (NCCC)
Kelly, Charles, MD Freeman Road
Kovarikova, Jarmila, MD Newcastle Upon Tyne, Tyne And Wear
NE7 7DN
(P) +441912231144 United Kingdom
(F) +441912820288
Freeman Hospital
Email: ruth.plummer@ncl.ac.uk (Pt Tx Ctr - Hosp/Med Ctr)
Sir Bobby Robson Cancer Research &
Trials Centre
The Northern Centre For Cancer Care
(NCCC)
Freeman Road
Newcastle Upon Tyne, Tyne And Wear
NE7 7DN
United Kingdom
CA209-037-0013* Middleton, Mark, MD Churchill Hospital (Office) 9

Old Road
Church, David, MD Oxford, Oxfordshire, OX3 7LJ
Coupe, Nicholas, MBBS United Kingdom
Gupta, Avinash, MBBS
Karydis, Ionna, MRCP Churchill Hospital
Malczewski, Agnieszka, MBBS (Pt Tx Ctr - Hosp/Med Ctr)
Saka, Wasir O, MB, BCH Old Road
Oxford, Oxfordshire, OX3 7LJ
(P) +4401865741841 United Kingdom
(F) +4401865768876
Email: mark.middleton@oncology.ox.ac.uk
9893
Approved v 1.0 930081508 1.0
CA209-037-0014 Amin, Asim, MD, PhD Levine Cancer Institute (Office) 5

1021 Morehead Medical Drive
Adams, Tesa, RN Charlotte, NC 28204
Barrineau, Tara B, MS USA
Brown, Miranda J.
Eddins, Debby Levine Cancer Institute
Hogan, Denise K, NP (Pt Tx Ctr - Hosp/Med Ctr)
Johnson-Elmore, Sharon D, RN 1021 Morehead Medical Drive
Parikh, Madhavi, PA-C Charlotte, NC 28204
Parker, Kimberly, RN USA
(P) 9804425300 Carolinas Medical Center

(F) 9804425261 (Pt Tx Ctr - Hosp/Med Ctr)
1000 Blythe Blvd.
Email: asim.amin@carolinashealthcare.org Charlotte, NC 28203
USA
CA209-037-0015 Grossmann, Kenneth, MD, PhD Huntsman Cancer Institute (Office) 13

2000 Circle Of Hope
Khong, Hung T, MD Salt Lake City, UT 84112
Luckett, Carolyn, NP USA
(P) 8015874573 Huntsman Cancer Institute

University Of Utah
Email: kenneth.grossmann@hci.utah.edu 2000 Circle Of Hope
Salt Lake City, UT 84112
USA
Huntsman Cancer Hospital

(Pt Tx Ctr - Hosp/Med Ctr)
University of Utah
1950 Circle Of Hope
Salt Lake City, UT 84112
USA
9894
Approved v 1.0 930081508 1.0
CA209-037-0016 Weber, Jeffrey S, MD, PhD H. Lee Moffitt Cancer Center & 23
Research Institute (Office)
Deconti, Ronald, MD 12902 Magnolia Dr.
Gibney, Geoffrey T, MD Tampa, FL 33612
Kudchadkar, Ragini, MD USA
Royster, Erica B, MPH
Thebeau, Melissa S, ARNP H. Lee Moffitt Cancer Center &
Research Institute
(P) 8137454960 (Pt Tx Ctr - Hosp/Med Ctr)
(F) 8137451835 12902 Magnolia Dr.
Tampa, FL 33612
Email: jeffrey.weber@moffitt.org USA
9895
Approved v 1.0 930081508 1.0
CA209-037-0017 Lawson, David H., MD Winship Cancer Institute (Office) 7

1365-C Clifton Rd. NE
Kopcewicz, Katarzyna Atlanta, GA 30322
Kurilo, Tatiana USA
Majdak, Susan
Maynard, Necia, NP Winship Cancer Institute
McKellar, Marjorie, PA (Pt Tx Ctr - Hosp/Med Ctr)
Mcmillan, Stephanie, RN 1365-C Clifton Rd. NE
Olaifa, Olalekan I Atlanta, GA 30322
USA
(P) 4047127485
(F) 4047784389 Emory University Hospital
Email: dlawson@emory.edu 1364 Clifton Rd. NE
Atlanta, GA 30322
USA
Emory University Hospital Midtown

550 Peachtree St. NE
Atlanta, GA 30308
USA
The Emory Clinic

(Pt Tx Ctr - Med Office/Clinic)
1365 Clifton Road NE
Drug Shipment Address Bldg. A
Investigational Drug Service, Ste 1200
Atlanta, GA 30322
USA
The Emory Clinic

1365 Clifton Rd. NE
Atlanta, GA 30322
USA
9896
Approved v 1.0 930081508 1.0
CA209-037-0018 Gonzalez, Rene, MD University Of Colorado Cancer Center 0

(Office)
Amaria, Rodabe Navroze, MD 1665 Aurora Court
Benchich, Katherine Shryock, NP Cutaneous Oncology, Mail Stop F703
Lewis, Karl, MD Anschutz Cancer Pavilion
Robinson, William A, MD Room 3240
Aurora, CO 80045
(P) 7208480584 USA
(F) 7208484021
University Of Colorado Cancer Center
Email: rene.gonzalez@ucdenver.edu (Pt Tx Ctr - Hosp/Med Ctr)
Anschutz Cancer Pavilion
1665 Aurora Ct
Aurora, CO 80045
USA
Anschutz Cancer Pavilion

1665 Aurora Court
Pharmacy, Room 2221
Aurora, CO 80045
USA
CA209-037-0019 Daud, Adil, MD UCSF Comprehensive Cancer Center 11

(Office)
Algazi, Alain, MD 1600 Divisadero Street
Ashworth, Michelle T, MD San Francisco, CA 94115
Buljan, Michael, NP USA
(P) 4153537052 UCSF Medical Center at Mount Zion

1600 Divisadero Street
Email: adaud@medicine.ucsf.edu San Francisco, CA 94115
USA
9897
Approved v 1.0 930081508 1.0
CA209-037-0020 Hodi, F. Stephen, MD Dana-Farber Cancer Institute (Office) 6

450 Brookline Ave
Beeler, Maureen, RN Boston, MA, 02215
Bhatt, Rupal S, MD USA
Bowers, Mary Ellen, RN
Buchbinder, Elizabeth I., MD Massachusetts General Hospital
Cho, Daniel C, MD (Pt Tx Ctr - Hosp/Med Ctr)
Davis, Meredith, PA-C 32 Fruit Street
Donahue, Hilary, MD Yawkey 8, Pharmacy
Fadden, Riley M., NP Boston, MA 02214
Flaherty, Keith T, MD USA
Haq, Rizwan, MD
Ibrahim, Nageatte, MD Massachusetts General Hospital
Kata, Caryn, RN (Pt Tx Ctr - Hosp/Med Ctr)
Kelley, Kristina, RN 55 Fruit Street
Lawrence, Donald, MD Boston, MA 02215
Lee, Mee-Young, NP USA
Livengood, Amanda J, RN
Luke, Jason, MD Dana-Farber Cancer Institute
Marujo, Rose, RN (Pt Tx Ctr - Hosp/Med Ctr)
McDermott, David, MD 450 Brookline Avenue
Mier, James, MD Boston, MA 02215
Ott, Patrick, MD USA
Renzi, Sharon, RN
Rubin, Krista, NP
Seery, Virginia, RN Dana-Farber Cancer Institute
Sullivan, Ryan, MD (Pt Tx Ctr - Hosp/Med Ctr)
Wood, Valerie J, RN 450 Brookline Ave.
Pharmacy - Yawkey Fl 5th
Boston, MA 02215
(P) 6176323786 USA
(F) 6176324301
Brigham & Women's Hospital
Email: stephen_hodi@dfci.harvard.edu (Pt Tx Ctr - Hosp/Med Ctr)
75 Francis St.
Boston, MA 02215
USA
9898
Approved v 1.0 930081508 1.0
CA209-037-0020 Beth Israel Deaconess Medical Center

Hodi, F. Stephen, MD (Pt Tx Ctr - Hosp/Med Ctr)
(cont’d) 330 Brookline Ave.
Boston, MA 02215
USA
CA209-037-0021 Pavlick, Anna Catherine, DO NYU Clinical Cancer Center (Office) 3

160 E 34th St.
Kannan, Rajni, ANP 9th Fl
Madden, Kathleen, FNP-C New York, NY 10016
USA
(P) 2127315757
(F) 2127315646 New York University Langone Medical
Center
Email: anna.pavlick@nyumc.org (Pt Tx Ctr - Hosp/Med Ctr)
Investigational Pharmacy
560 First Ave. HN300
New York, NY 10016
USA
New York University Langone Medical

Center
550 First Avenue
New York, NY 10016
USA
New York University Clinical Cancer

Center
Pt Tx Ctr - Hosp/Med Ctr)
160 E 34th St.
New York, NY 10016
USA
9899
Approved v 1.0 930081508 1.0
CA209-037-0022 Sosman, Jeffrey A, MD Vanderbilt-Ingram Cancer Center 11

(Office)
Ancell, Kristin K, MD 2220 Pierce Ave.
Kelley, Mark, MD 777 Preston Research Bldg
Puzanov, Igor, MD Nashville, TN 37232
Wallace, Deborah E, APN USA
Wyman, Kenneth W, MD
Vanderbilt Oncology Pharmacy
(P) 6159368422 (Pt Tx Ctr - Med Office/Clinic)
(F) 6159365850 The Vanderbilt Clinic Rm 2906
1301 Medical Ctr Dr.
Email: jeff.sosman@vanderbilt.edu Nashville, TN 37232
USA
Henry-Joyce Cancer Clinic

1301 Medical Ctr Dr.
1900 Vanderbilt Clinic
Nashville, TN 37232-5536
USA
CA209-037-0023 Thomas, Sajeve, MD Orlando Health, Inc (Office) 9

Pennock, Gregory K, MD (Previous) 1400 South Orange Avenue
Orlando, FL 32806
Johnson, Tirrell, MD USA
Landau, Daniel A, MD
Maddipatla, Sreeram, MD MD Anderson Cancer Center Orlando
Thomas, Sajeve, MD (Office) (Previous)
1400 S Orange Ave.
(P) 4076483800 Orlando, FL 32806
(F) 4074230840 USA
Email: sajeve.thomas@orlandohealth.com Orlando Regional Medical Center

(Pt Tx Ctr - Hosp/Med Ctr) (Previous)
1414 S Orange (kuhl) Ave.
Orlando, FL 32806 USA
9900
Approved v 1.0 930081508 1.0
Orlando Heart Health Institute
CA209-037-0023 (Pt Tx Ctr - Hosp/Med Ctr) (Previous)
Thomas Sajeve, MD 1222 South Orange Ave.
(Cont’d) Orlando, FL 32806
USA
Orlando Health, Inc

1400 South Orange Avenue
Orlando, FL 32806
USA
Orlando Health, Inc

1400 S Orange Ave.
5th Floor Investigational Pharmacy
MP720 Drug Shipment
Orlando, FL 32806
USA
MD Anderson Cancer Center Orlando (Pt

Tx Ctr - Hosp/Med Ctr) (Previous)
5th Fl Investigational Pharm
1400 S. Orange Ave. MP 720
Drug Shipment
Orlando, FL 32806
USA
Md Anderson Cancer Center Orlando

1400 S Orange Ave.
Orlando, FL 32806
USA
9901
Approved v 1.0 930081508 1.0
CA209-037-0024 Hamid, Omid, MD The Angeles Clinic & Research Institute 5
(Office)
Balmanoukian, Ani, MD 11818 Wilshire Blvd.
Boasberg, Peter D, MD Ste 200
Chung, Cathie, MD Los Angeles, CA 90025
Hoffner, Brianna, NP USA
(P) 3102940438 The Angeles Clinic & Research Institute

(F) 3102312199 (Pt Tx Ctr - Med Office/Clinic)
2001 Santa Monica Blvd.
Email: ohamid@theangelesclinic.org Ste 560W
Santa Monica, CA 90404
USA
The Angeles Clinic & Research Institute

11818 Wilshire Blvd.
Ste 200
Los Angeles, CA 90025
USA
9902
Approved v 1.0 930081508 1.0
CA209-037-0025 Infante, Jeffrey R, MD Tennessee Oncology, PLLC (Office) 4
250 25th Avenue North
Bauer, Todd, MD Suite 307
Bendell, Johanna Chock, SB, MD Nashville, TN 37203
Bi, Jia, MD USA
Burris, III, Howard A, MD
Cooper, Robert S, MD Tennessee Oncology, PLLC
Dickson, Natalie Renee, MD (Pt Tx Ctr - Med Office/Clinic)
Greco, F. Anthony, MD 4230 Harding Rd. Ste 707
Hollis, Laura T, APRN, BC Nashville, TN, 37205
Hronek, Jan W, ACNP USA
Ingle, Rebecca J, FNP
Lehner, Maureen E, ACNP Tennessee Oncology, PLLC
Morris, Patricia A, APN-C (Pt Tx Ctr - Med Office/Clinic)
Porter III, Lester L, MD 250 25th Avenue North
Shepard, Gregg Christian, MD Suite 100
Shih, Kent C, MD Nashville, TN 37203
Spigel, David Robert, MD USA
Thompson, Dana Shelton, MD
Utley, Susan M., BSN, MSN, FNP Sarah Cannon Research Institute
Vantrease, Amanda G, APN, RN (Pt Tx Ctr - Med Office/Clinic)
Yardley, Denise Aysel, MD 250 25th Ave. N
St 312
(P) 6153421741 Nashville, TN 37203
(F) 6153421738 USA
Email: jinfante@tnonc.com Sarah Cannon Research Institute

250 25th Ave. N
St 307
Nashville, TN 37203
USA
9903
Approved v 1.0 930081508 1.0
CA209-037-0027 Linette, Gerald P, MD, PhD Washington University School of 14
Medicine (Office)
Cornelius, Lynn Anne, MD 660 South Euclid Ave.
Curran, Christen M, MSN, RN, ANP-BC St. Louis, MO 63110
Tan, Benjamin, MD USA
Wildes, Tanya M, MD
Washington University School of
(P) 3147471217 Medicine
Site Man Cancer Ctr.
Email: glinette@dom.wustl.edu 4921 Parkview Pl. Fl 7th
Saint Louis, MO 63110
USA
Washington University Infusion Center

Pharmacy
4921 Parkview Pl. Ste 7F
USA
Barnes-Jewish Hospital
1 Barnes-Jewish Hosp Plz.
USA
9904
Approved v 1.0 930081508 1.0
CA209-037-0028 D'angelo, Sandra Pierina, MD Memorial Sloan Kettering Cancer Center 24
(Office)
Callahan, Margaret Kathleen, MD, PhD 1275 York Ave.
Carvajal, Richard D, MD Inpatient Hospital & Main Campus
Chapman, Paul B, MD New York, NY 10065
Chi, Ping, MD, PhD USA
Dickson, Mark A, MD
Erinjeri, Joseph P, MD, PhD Memorial Sloan-Kettering Cancer Center
Gounder, Mrinal M, MD (Pt Tx Ctr - Hosp/Med Ctr)
Harding, James J, MD Laurence S. Rockefeller Outpatient
Keohan, Mary Louise, MD Pavillion
Lefkowitz, Robert Andrew, MD 160 East 53rd Street
Postow, Michael A, MD New York, NY 10022
Schwartz, Gary K, MD USA
Tap, William D, MD
Weinstein, Alyona, NP Memorial Sloan Kettering Cancer Center
Wolchok, Jedd, MD, PhD (Pt Tx Ctr - Hosp/Med Ctr)
1275 York Ave. RM C-1087
(P) 6462272189 Attn: Gerry O-Neill
(F) 6464222164 New York, NY 10065
USA
Email: dangelos@mskcc.org
Memorial Sloan Kettering Cancer Center
1275 York Ave
Inpatient Hospital & Main Campus
New York, NY 10065
USA
9905
Approved v 1.0 930081508 1.0
CA209-037-0029 Chmielowski, Bartosz, MD, PhD University of California - Los Angeles 14
Hematology-Oncology Outpatient Clinic
Branch, Suzanne, CCRP (Office)
Glaspy, John A., MD, MPH 100 UCLA Medical Plaza
Oseguera, Denise K, FNP Suite 550
Ribas, Antoni, MD Los Angeles, CA 90095
Tumeh, Paul, MD USA
(P) 3107944955 Westwood Bowyer Clinic

200 UCLA Medical Plaza
Email: bchmielowski@mednet.ucla.edu Suite 120
USA
University of California - Los Angeles

Hematology-Oncology Outpatient Clinic
Suite 550
USA
UCLA Dermatology Clinic

Suite 450
USA
Ronald Reagan UCLA Medical Center

Surgery Center
200 Medical Plaza
6th Floor
USA
9906
Approved v 1.0 930081508 1.0
CA209-037-0029 Ronald Reagan Ucla Medical Center
Chmeilowski, Bartosz, MD, (Pt Tx Ctr - Hosp/Med Ctr)
PhD (Cont’d) Department of Radiological Sciences
757 Westwood Plaza
USA
Ronald Reagan UCLA Medical Center

662 Gayley Avenue Room B504A
Drug Information Center
Dept. of Pharmaceutical Services
USA
Clinical Research Unit

924 Westwood Plaza
Suite 200
USA
9907
Approved v 1.0 930081508 1.0
CA209-037-0030 Agarwala, Sanjiv S., MD St.Luke's Cancer Center (Office) 6
Anderson Campus
Ali, Asim, MD 1600 Riverside Circle
Belman, Neil, DO Easton, PA 18045
Faroun, Yacoub, MD USA
Holden, Rita, CRNP
Leonard, Jillian Foster, PA-C St.Luke's Quakertown Hospital
Nakajima, Hikaru, MD (Pt Tx Ctr - Hosp/Med Ctr) (Previous)
Peartree, Michelle, PA-C 1021 Park Ave
Proothi, Subhash, MD Quakertown, PA 18951
USA
(P) 4845034500
(F) 4845034510 St.Luke's Cancer Center
Email: agarwas@slhn.org Anderson Campus
1600 Riverside Circle
Easton, PA 18045
USA
St.Luke's Cancer Center

Allentown Campus
1736 Hamilton Street
Allentown, PA 18104
USA
St.Luke's Cancer Center

Anderson Campus
1872 Riverside Circle
Easton, PA 18045
USA
9908
Approved v 1.0 930081508 1.0
CA203-037-0030 St. Luke's University Hospital
Agarwala, Sanjiv, S., MD Bethlehem Campus
(Cont’d) (Pt Tx Ctr - Hosp/Med Ctr)
801 Ostrum St.
Bethlehem, PA 18015
USA
St. Luke'S Cancer Center - Allentown

Campus (Pt Tx Ctr - Hosp/Med Ctr)
240 Cetronia Rd.
Allentown, PA 18104
USA
Cancer Care Associates Medical

Oncology (Pt Tx Ctr - Hosp/Med Ctr)
701 Ostrum St.
Ste 403
Bethlehem, PA 18015
USA
Cancer Care Associates Medical

Oncology (Pt Tx Ctr - Hosp/Med Ctr)
240 Cetronia Road
Suite 225 South
Allentown, PA 18104
USA
St. Luke's Hospital - Quakertown

Campus (Pt Tx Ctr - Med Office/Clinic)
1021 Park Ave.
Quakertown, PA 18951
USA
9909
Approved v 1.0 930081508 1.0
CA209-037-0031 Daniels, Gregory, MD, PhD UCSD Moores Cancer Center (Office) 4
3855 Health Sciences Dr.
Sutton, Brian C, PA-C La Jolla, CA 92093
USA
(P) 8588226083
(F) 8588225380 UCSD Medical Center- Hillcrest
Email: gdaniels@ucsd.edu 200 W Arbor Dr.
San Diego, CA 92103
USA
UCSD Medical Center - La Jolla

9300 Campus Point Dr.
La Jolla, CA 92037
USA
UCSD Moores Cancer Center

Investigational Drug Services
3855 Health Science Drive
Room 1036
La Jolla, CA 92037
USA
UCSD Moores Cancer Center

3855 Health Sciences Dr.
La Jolla, CA 92093
USA
9910
Approved v 1.0 930081508 1.0
CA209-037-0033 Urba, Walter J, MD, PhD Providence Oncology and Hematology 4

Care (Office)
Abar, Farnoush, MD 4805 NE Glisan Street
Barber, Nicholas Andrew, MD #6N40/2N35
Conlin, Alison K., MD Portland, OR 97213
Crocenzi, Todd S, MD USA
Curti, Brendan, MD
Eddington, Joanne T, NP Providence St. Vincent Medical Center
Godwin, John Edward, MD (Pt Tx Ctr - Hosp/Med Ctr)
Griswold, Roxanne R, NP 9205 SW Barnes Rd.
Kefer, Catherine A, NP Portland, OR 97225
Kurup, Anupama, MD USA
Lanier, Keith S, MD
Leidner, Rom S, MD Providence Portland Medical Center
Lewis, Stacy K., MD (Pt Tx Ctr - Hosp/Med Ctr)
Li, Rui, MD, PhD 4805 NE Glisan St.
Lin, Christine L, MD Portland, OR 97213
Myklebust, Erin K, NP USA
Sanborn, Rachel E, MD
Zilverberg, Jamie Rae, NP Providence Oncology and Hematology
Care Westside
(F) 5032156725 9135 SW Barnes Road
Suite 261
Email: walter.urba@providence.org Portland, OR 97225
USA
Providence Oncology & Hematology

Care Eastside
4805 NE Gilsan St. #6N40
Portland, OR 97213
USA
9911
Approved v 1.0 930081508 1.0
CA209-037-0033 Providence Health and Services
Urba, Walter, J, MD, PhD (Pt Tx Ctr - Hosp/Med Ctr)
(Cont’d) 4805 NE Glisan Street
IDS: Suite 6N-45
Portland, OR 97213
USA
CA209-037-0034 Sznol, Mario, MD Yale University School of Medicine 12

Section of Medical Oncology
Kluger, Harriet, MD (Office)
333 Cedar St. FMP 126
(P) 2037854796 New Haven, CT 06520
(F) 2037857273 USA
Email: mario.sznol@yale.edu Smilow Cancer Hospital at Yale New

Haven Hospital
266 South Frontage Road
Onc. Pharm, 8th FL Rm 8-110
New Haven, CT 06510
USA
Smilow Cancer Hospital at Yale New

Haven Hospital
20 York Street
New Haven, CT 06510
USA
9912
Approved v 1.0 930081508 1.0
CA209-037-0035 Salama, April, MD Duke University Medical Center (Office) 7
200 Trent Drive
Hanks, Brent A, MD Box 3476, Room 459 Sealey G Mudd
Herrmann, Tara Rae, PA Building, Box 3118
Linney, Kristen, RN Durham, NC 27710
Morse, Michael A, MD USA
Mosca, Paul Jo, MD
Ready, Neal, MD Duke University Medical Center (Office)
Riedel, Richard, MD (Previous)
Scheri, Randall P, MD Box 3476, Room 459 Seely G. Mudd
Tyler, Douglas, MD Building
Durham, NC 27710
(P) 9195757213 USA
(F) 9195757042
Duke University Medical Center
Email: april.salama@duke.edu (Pt Tx Ctr - Hosp/Med Ctr)
200 Trent Drive
Durham, NC 27710
USA
CA209-037-0036* Grob, Jean-Jacques, MD, PhD Hopital La Timone (Office) 7

Service de Dermatologie
Archier, Elodie Pavillon 3
Baudoux, Laure, MD 270 Blvd. Sainte-Marguerite
Bruneu, Yvane, MD Marseille, 13009
Durieux, Olivier, MD France
Gaudy, Caroline, MD
Hesse, Sylvie, MD Hopital La Timone
Levy, Anna, MD (Pt Tx Ctr - Hosp/Med Ctr)
Mallet, Stephanie, MD Service Dermatologie
Monestier, Sandrine, MD 264 rue Saint Pierre
Richard, Marie-Aleth, MD Marseille Cedex 5, 13385
France
(P) +33491387065
(F) +33491387989
Email: jean-jacques.grob@ap-hm.fr
9913
Approved v 1.0 930081508 1.0
CA209-037-0037* Robert, Caroline, MD Institut Gustave Roussy (Office) 7
Service Dermatologie
Boussemart, Lise, MD 39 rue Camille Desmoulins
Cazenave, Hugo, MD Villejuif, 94805
Mateus, Christine, MD France
Routier, Emilie, MD
Sebille, Gwendoline, MD Institut Gustave Roussy
Thomas, Marina, MD (Pt Tx Ctr - Hosp/Med Ctr)
Viollet, Roxane, MD, PhD Service Dermatologie
39 rue Camille Desmoulins
(P) +33142114211 Villejuif, 94805
(F) +33142115300 France
Email: caroline.robert@gustaveroussy.fr
CA209-037-0038* Lebbe, Celeste, MD, PhD Hopital Saint Louis (Office) 5
1 Avenue Claude Vellefaux
Basset-Seguin, Nicole, MD Paris, 75010
Bouaziz, Jean-David, MD France
Bruzzoni, Heriberto, MD
Kiladjian, Jean-Jacques, MD Hopital Saint Louis
Pages, Cecile, MD (Pt Tx Ctr - Hosp/Med Ctr)
Roux, Jennifer, MD Hopital Saint Louis
Sabatier, Francois, MD Dept Dermatologie
Schneider, Pierre, MD 1 Avenue Claude Vellefaux
Servy, Amandine, MD Paris, 75010
Viguier, Manuelle, MD France
(P) +33142499575
(F) +33142494227
Email: celeste.lebbe@sls.aphp.fr
9914
Approved v 1.0 930081508 1.0
CA209-037-0039* Dreno, Brigitte, MD Hotel Dieu - Chu De Nantes (Office) 4
1 Place Alexis Ricordeau
Brocard, Anabelle, MD Nantes Cedex 1, Na, 44093
Dupas, Benoit, MD, PhD France
Peuvrel, Lucie, MD
Quereux, Gaelle, MD Hotel Dieu - Chu De Nantes
Saint-Jean, Melanie, MD (Pt Tx Ctr - Hosp/Med Ctr)
Unite Cancero-Dermatologie
(P) +33240083333 1 Place Alexis Ricordeau
(F) +33240083250 Nantes Cedex 1, Na, 44093
France
Email: brigitte.dreno@wanadoo.fr
CA209-037-0040* Thomas, Luc, MD, PhD Centre Hospitalier Lyon Sud (Office) 10
Pavillon Medical, Service Dermatologie
Amini-Adle, Mona, MD PC Medicaux 3Eme Estage
Dalle, Stephane, MD 165 chemin du Grand Revoyet
Pierre Benite, 69495
(P) +33825082569 France
(F) +33478864410
Centre Hospitalier Lyon Sud
Email: luc.thomas@chu-lyon.fr (Pt Tx Ctr - Hosp/Med Ctr)
PC Medicaux 3Eme Estage
165 chemin du Grand Revoyet
Pierre Benite, 69310
France
9915
Approved v 1.0 930081508 1.0
CA209-037-0041 Flaherty, Lawrence, MD Karmanos Cancer Institute (Office) 2
4100 John R
Lefkotwitz, Nancy, RN, MPH Detroit, MI 48201
Lewis, Rena, RN USA
Marsack, Cynthia H., MSN, RN, OCN, CS, NP
Miller, Elizabeth K, MHS, PA-C Karmanos Cancer Institute
Murray, Jennifer E, RN (Pt Tx Ctr - Hosp/Med Ctr)
Trojniak, Lynette Marie, MSN, RN, CNP 4100 John R
Vaishampayan, Ulka N, MD Detroit, MI 48201
USA
(P) 3135768808
(F) 3135768825 Karmanos Cancer Institute Of
Farmington Hills
Email: flaherty@karmanos.org (Pt Tx Ctr - Hosp/Med Ctr)
31995 Northwest Hwy.
Farmington Hills, MI 48334
USA
9916
Approved v 1.0 930081508 1.0
CA209-037-0042 Lutzky, Jose, MD Mount Sinai Medical Center 5
(Office)
Blaustein, Arnold, MD Comprehensive Cancer Center
Cusnir, Mike, MD 4306 Alton Rd.
Krill-Jackson, Elisa, MD Miami Beach, FL 33140
Pizzolato, Joseph, MD USA
Rodriguez, Estelamari, MD
Schwartz, Michael, MD Mount Sinai Medical Center
(P) 3055353350 4300 Alton Rd
(F) 3056743984 Miami Beach, FL 33140
USA
Email: jose.lutzky@msmc.com
Mount Sinai Medical Center
Comprehensive Cancer Center
4306 Alton Rd.
Miami Beach, FL 33140
USA
Mount Sinai Comprehensive Cancer

Center at Aventura
2845 Aventura Blvd.
Aventura, FL 33180
USA
9917
Approved v 1.0 930081508 1.0
CA209-037-0043 Khushalani, Nikhil, MD Roswell Park Cancer Institute (Office) 11
Elm And Carlton Streets
Cheney, Richard T, MD Buffalo, NY 14263
George, Saby MD USA
Loud, Peter A, MD
Skitzki, Joseph, MD Roswell Park Cancer Institute
(P) 7168452300 Elm And Carlton Streets
(F) 7168458661 Buffalo, NY 14263
USA
Email: nikhil.khushalani@roswellpark.org
CA209-037-0044 Bryce, Alan H., MD Mayo Clinic (Office) 10

13400 E Shea Blvd
Camoriano, John, MD Scottsdale, AZ 85259
Cohen, Peter Aver, MD USA
Curtis, Kelly K, MD
Northfelt, Donald, MD Mayo Clinic
Paripati, Harshita R, MD (Pt Tx Ctr - Hosp/Med Ctr)
Torigian, Robert, PA 13400 E Shea Blvd
Scottsdale, AZ 85259
(P) 4803016198 USA
(F) 4803017991
Email: bryce.alan@mayo.edu
9918
Approved v 1.0 930081508 1.0
CA209-037-0046 Nair, Suresh G, MD Network Office of Research and 1
Innovation (Office)
Agostino, Nicole M, DO 1210 Bldg, Suite 1000
Barnaby, Janine G, RPh Cedar Crest Blvd & I-78
Bolsover, Kathleen Marie, RN LVH/LVHN
Candelo, Yasmin, RN Allentown, PA 18103
Chase, Ramona E, CRNP USA
Ferguson, Tracey A, RN
Friedman, Eliot L, MD Lehigh Valley Health Network
Gallagher, Debra (Pt Tx Ctr - Hosp/Med Ctr)
Gardner, Nancy Sue, CRNP Cedar Crest Boulevard & I-78
Grace, Trina Lehigh Valley Hospital (LVH/LVHN)
Harris, Katherine A, MD Allentown, PA 18103
Kotkiewicz, Adam, DO USA
Lamparella, Nicholas, MD
Lichtenwalner, Sarah Elizabeth, RN
Patson, Brian J, MD
Scialla, William S, DO
Shah, Ashish Prabodh, MD
Shah, Usman, MD
Skandan, Savitri, MD
Smith, Georgeanne, CLA
Whitney, Samiyyah, RN
(P) 6104022273
(F) 6104020634
Email: suresh.nair@lvh.com
9919
Approved v 1.0 930081508 1.0
CA209-037-0047 Lao, Christopher, MD University of Michigan Health System 14
(Office)
Patton, Susan, RN, BSN 1500 East Medical Ctr Dr.
Redman, Bruce, DO Ann Arbor, MI 48109
USA
(P) 7349365215
(F) 7347635793 University of Michigan Health System
Email: clao@umich.edu 1500 East Medical Ctr Dr.
Ann Arbor, MI 48109
USA
CA209-037-0048 Kirkwood, John M, MD Hillman Cancer Center 5

(Office)
Rusilko, Cathryn, PA-C 5117 Centre Ave.
Shipe-Spotloe, Janice, PA-C Research Pavillion, 1.32C
Tarhini, Ahmad, MD Pittsburgh, PA 15232
Tawbi, Hussein Abdul-Hassan, MD USA
Wilson, Melissa PA-C
Zarour, Hassane, MD UPMC Cancer Pavilion
(Office) (Previous)
(P) 4122321020 5150 Ctr Ave. 5th Fl
(F) 4126234655 Pittsburgh, PA 15232
USA
Email: kirkwoodjm@upmc.edu
UPMC Cancer Center
(Office) (Previous)
5117 Centre Ave, 1.32c
Hillman Cancer Center
Pittsburgh, PA 15232
USA
Hillman Cancer Center

5115 Ctr Ave.
Pittsburgh, PA 15232
USA
9920
Approved v 1.0 930081508 1.0
CA209-037-0049 Koon, Henry B, MD University Hospitals of Cleveland 6
(Office)
Bray, Julie, CNP 11100 Euclid Ave.
Nock, Charles J, MD Cleveland, OH 44106
USA
(P) 2168443681
(F) 2168443448 University Hospitals of Cleveland
Email: henry.koon@uhhospitals.org 11100 Euclid Ave.
Cleveland, OH 44106
USA
Chagrin Highlands
3909 Orange Place
Cleveland, OH 44122
USA
9921
Approved v 1.0 930081508 1.0
CA209-037-0050 Minor, David R, MD San Francisco Oncology Associates 28
(Office)
Wang, Wei, MD, PhD 2100 Webster St.
Ste 326
(P) 4156003027 San Francisco, CA 94115
(F) 4156001737 USA
Email: minord@sutterhealth.org San Francisco Oncology Associates

2100 Webster St.
Ste 326
San Francisco, CA 94115
USA
Pacific Hematology Oncology

Associates
2100 Webster St.
Ste 225
USA
California Pacific Medical Center

2333 Buchanan St.
USA
California Pacific Medical Center

Research Institute
2200 Webster St.
4th Flr/ste 411 (drug Shpmt)
San Francisco, CA 94115-1932
USA
9922
Approved v 1.0 930081508 1.0
CA209-037-0051* Maio, Michele, MD Azienda Ospedaliera Universitaria 10
Senese (Office)
Calabro, Luana, MD U.O.C. Immunoterapia Oncologica
Danielli, Riccardo, MD Strade Delle Scotte, 14
Di Giacomo, Anna Maria, MD Siena, 53100
Italy
(P) +390577586199
(F) +390577586599 Azienda Ospedaliera Universitaria
Senese
Email: mmaiocro@gmail.com (Pt Tx Ctr - Hosp/Med Ctr)
U.O.C. Immunoterapia Oncologica
Strade Delle Scotte, 14
Siena, 53100
Italy
CA209-037-0052* Ascierto, Paolo Antonio, MD Istituto Nazionale Tumori Fondazione 9

Pascale (Office)
D'Aniello, Carmine, MD Istituto Nazionale Dei Tumori
Grimaldi, Antonio Maria, MD Via Mariano Semola,1
Simeone, Ester, MD Napoli, 80131
Italy
(P) +390815903227
(F) +390815903821 Istituto Nazionale Tumori Fondazione
Pascale (Pt Tx Ctr - Hosp/Med Ctr)
Email: paolo.ascierto@gmail.com Istituto Nazionale Dei Tumori
Via Mariano Semola,1
Napoli, 80131
Italy
9923
Approved v 1.0 930081508 1.0
CA209-037-0053* Chiarion-Sileni, Vanna, MD Irccs Istituto Oncologico Veneto IOV 3
(Office)
Pigozzo, Jacopo, MD IOV - SSD Oncologia Melanomi
Valpione, Sara, MD Via Gattamelata 64
Padova, 35128
(P) +390498215838 Italy
(F) +390498215837
Irccs Istituto Oncologico Veneto IOV
Email: vanna.chiarion@ioveneto.it (Pt Tx Ctr - Hosp/Med Ctr)
IOV - SSD Oncologia Melanomi
Via Gattamelata 64
Padova, 35128
Italy
CA209-037-0055* Ferraresi, Virginia, MD Istituto Regina Elena (Office) 4

Oncologia Medica A
Garufi, Carlo, MD Via Elio Chianesi, 53
Nuzzo, Carmen, MD Roma, 00144
Torsello, Angela, MD Italy
Zeuli, Massimo, MD
Istituto Regina Elena
(F) +392665523 Oncologia Medica A
Via Elio Chianesi, 53
Email: ferraresi@ifo.it Roma, 00144
Italy
9924
Approved v 1.0 930081508 1.0
CA209-037-0056* Queirolo, Paola, MD Istituto Nazionale Per La Ricerca Sul 6
Cancro (Office)
Biello, Federica, MD Oncologia Medica A
Monteghirfo, Stefano, MD Largo Rosanna Benzi, 10
Ottaviano, Vincenzo, MD Genova, 16132
Pesce, Marianna, MD Italy
Picasso, Virginia, MD
Spagnolo, Francesco, MD Istituto Nazionale Per La Ricerca Sul
Tornari, Elena, MD Cancro
(P) +390105600665 Oncologia Medica A,
(F) +390105600850 Largo Rosanna Benzi, 10
Genova, 16132
Email: paola.queirolo@istge.it Italy
CA209-037-0057* Testori, Alessandro, MD Istituto Europeo Di Oncologia 10

(Office)
Baldini, Federica, MD Divisione Melanoma E Sarcomi
Cocorocchio, Emilia, MD Muscolo-cutanei
Ferrucci, Pier Francesco, MD Via Ripamonti, 435
Spadola, Giuseppe, MD Milano, 20141
Italy
(P) +390257489848
(F) +390257489781 Istituto Europeo Di Oncologia
Email: alessandro.testori@ieo.it Divisione Melanoma E Sarcomi
Muscolo-cutanei
Via Ripamonti, 435
Milano, 20141
Italy
9925
Approved v 1.0 930081508 1.0
CA209-037-0058* Guida, Michele, MD Giovanni Paolo II Istituto 2
(Office)
Latorre, Agnese, MD Viale Orazio Flacco 65
Strippoli, Sabino, MD Bari, 70124
Italy
(P) +390805555256
(F) +390805555471 Giovanni Paolo II Istituto
Email: micguida@libero.it Viale Orazio Flacco 65
Bari, 70124
Italy
CA209-037-0059* Hogg, David, MD Princess Margaret Hospital 6

(Office)
Butler, Marcus, MD Room 5-124
Gedye, Craig Alastair, MD 610 University Ave.
Joshua, Anthony, MD Toronto, ON, M5G 2M9
Spreafico, Anna, MD Canada
(P) 4169464522 Princess Margaret Hospital

Room 5-124
Email: david.hogg@uhn.ca 610 University Ave.
Toronto, ON, M5G 2M9
Canada
9926
Approved v 1.0 930081508 1.0
CA209-037-0060* Jamal, Rahima, MD Chum, Hopital Notre-Dame (Office) 5
Pavillon Deschamps 5th Floor
Aubin, Francine, MD 1560 Sherbrooke E.
Ayoub, Jean-Pierre, MD Montreal, QC, H2L 4M1
Belanger, Karl, MD Canada
Bestawros, Alain
Blais, Normand, MD Chum-Hopital Notre-Dame
Charpentier, Danielle, MD (Pt Tx Ctr - Hosp/Med Ctr)
Lemieux, Bernard, MD Oncology Center
Soulieres, Denis, MD CHUM - Hopital Notre-Dame
Tehfe, Mustapha, MD 1560 Sherbrooke E.
Montreal, QC, H2L 4M1
(P) 5148908000 Canada
(F) 5144127572
Email: rahima.jamal.chum@ssss.gouv.qc.ca
CA209-037-0061* Miller, Wilson, MD Sir Mortimer B. Davis-Jewish General 16

Hospital
Friedmann, Jennifer, MD (Office)
Jamal, Rahima, MD 3755 Cote Ste-Catherine
Kavan, Petr, MD Montreal, Quebec, H3T 1E2
Palumbo, Michael, MD Canada
Patenaude, Francois, MD
Sir Mortimer B. Davis Jewish General
Hospital
(F) 5143407555 3755 Cote Ste-Catherine
Montreal, Quebec, H3T 1E2
Canada
Email: wmiller@ldi.jgh.mcgill.ca
9927
Approved v 1.0 930081508 1.0
CA209-037-0062* Smylie, Michael G, MD Cross Cancer Institute (Office) 17
11560 University Ave NW
Chu, Siu-Chung Quincy, MD Edmonton, AB, T6G 1Z2
Joy, Anil Abraham, MD Canada
Walker, John, MD
Cross Cancer Institute
(P) 7809898157 11560 University Ave NW
(F) 7805778138 Edmonton, AB, T6G 1Z2
Canada
Email: michaels@cancerboard.ab.ca
CA209-037-0063* Schmidt, Henrik, MD Aarhus University Hospital (Office) 9

Norrebrogade 44
Fode, Kirsten, MD Aarhus, 8000
Denmark
(P) +4578461682
(F) +4578462530 Aarhus University Hospital
Email: henrschm@rm.dk Dept Of Oncology
Norrebrogade 44
Aarhus C, 8000
Denmark
CA209-037-0064* Bastholt, Lars, MD Odense University Hospital (Office) 1

Sdr. Boulevard 29
Eriksen, Jesper, MD Odense, 5000
Gyldenkerne, Niels, MD Denmark
(P) +4566113333 Odense University Hospital

Dept Of Oncology R
Email: lars.bastholt@rsyd.dk Sdr. Boulevard 29
Odense C, 5000
Denmark
9928
Approved v 1.0 930081508 1.0
CA209-037-0065* Svane, Inge Marie, MD, PhD Herlev Hospital (Office) 5
Herlev Ringvej
Donia, Marco, MD, PhD Herlev, 2730
Engel Norregaard, Lotte, MD, PhD Denmark
Geertsen, Poul, MD, PhD
Mathiessen, Louise Wichman, MD, PhD Herlev Hospital
Sengelov, Lisa, MD (Pt Tx Ctr - Hosp/Med Ctr)
Skovgaard, Kristin, MD, PhD Dept. Of Oncology
Herlev Ringvej 75
(P) +4544884488 Herlev, DK-2730
(F) +4544883033 Denmark
Email: imsv@heh.regionh.dk
CA209-037-0066* Del Vecchio, Michele, MD Istituto Nazionale Tumori (Office) 2

Via Venezian, 1
Colonna, Valentina, MD Milano, 20133
Di Guardo, Lorenza, MD Italy
Duca, Matteo, MD
Pilla, Lorenzo, MD Istituto Nazionale Tumori
(P) +390223902882 Via Venezian, 1
(F) +390223902149 Milano, 20133
Italy
Email: michele.delvecchio@istitutotumori.mi.it
9929
Approved v 1.0 930081508 1.0
CA209-037-0067 Hodi, F. Stephen, MD Dana Farber Cancer Institute 7
(Office)
Beeler, Maureen, RN 450 Brookline Ave
Bhatt, Rupal S, MD Boston, MA 02215
Bowers, Mary Ellen, RN USA
Buchbinder, Elizabeth I., MD
Cho, Daniel C., MD Massachusetts General Hospital
Davis, Meredith, PA-C (Pt Tx Ctr - Hosp/Med Ctr)
Donahue, Hilary, MD 32 Fruit Street
Fadden, Riley M., NP Yawkey 8, Pharmacy
Flaherty, Keith T, MD Boston, MA 02214
Haq, Rizwan, MD USA
Ibrahim, Nageatte, MD
Kata, Caryn, RN Massachusetts General Hospital
Kelley, Kristina, RN (Pt Tx Ctr - Hosp/Med Ctr)
Lawrence, Donald, MD 55 Fruit Street
Lee, Mee-Young, NP Boston, MA 02215
Livengood, Amanda J., RN USA
Luke, Jason, MD
Marujo, Rose, RN Dana-Farber Cancer Institute
McDermott, David, MD (Pt Tx Ctr - Hosp/Med Ctr)
Mier, James, MD 450 Brookline Avenue
Ott, Patrick, MD Boston, MA 02215
Renzi, Sharon, RN USA
Rubin, Krista, RN
Seery, Virginia, RN
Sullivan, Ryan, MD Dana-Farber Cancer Institute
Wood, Valerie J, RN (Pt Tx Ctr - Hosp/Med Ctr)
450 Brookline Ave
Pharmacy - Yawkey Fl 5th
(P) 6176323786 Boston, MA 02215
(F) 6176324301 USA
Email: stephen_hodi@dfci.harvard.edu Brigham & Women's Hospital

Email: (Pt Tx Ctr - Hosp/Med Ctr)
75 Francis St
Boston, MA 02215
USA
9930
Approved v 1.0 930081508 1.0
CA209-037-0067 Beth Israel Deaconess Medical Center(Pt
Hodi, F. Stephen, MD Tx Ctr - Hosp/Med Ctr)
(Cont’d) 330 Brookline Ave
Boston, MA 02215
USA
CA209-037-0068* Garbe, Claus, MD Universitaetsklinikum Tuebingen 3

(Office)
Eigentler, Thomas, MD Liebermeisterstr. 25
Held, Laura, MD Tubingen, 72076
Jradi, Zeinab, MD Germany
Pierchalla, Kathrin, MD
Tampouri, Ioanna, MD Universitaetsklinikum Tuebingen
Thomas, Ioannis, MD (Pt Tx Ctr - Hosp/Med Ctr)
Weide, Benjamin, MD Liebermeisterstr. 25
Tubingen, 72076
(P) +49070712985748 Germany
(F) +49070712952655
Email: claus.garbe@med.uni-tuebingen.de
CA209-037-0069* Hassel, Jessica, MD Nationales Centrum Fuer 13
Tumorerkrakungen (NCT) Heidelberg
Berthold, Elisa, MD (Office)
Delavari, Delnaz Uniklinik Heidelberg
Hofmann, Frank, MD Im Neuenheimer Feld 460
Lang, Nina, MD Dermatoonkologie
Lee, Sophia B, MD Heidelberg, 6912
Lonsdorf, Anke Susanne, MD Germany
Salz, Mareen, MD
Schiller, Matthias Bastian, MD Nationales Centrum Fuer
Tumorerkrakungen (NCT) Heidelberg
(P) +4962215638522 (Pt Tx Ctr - Unspecified)
(F) +4962215688902 Uniklinik Heidelberg
Im Neuenheimer Feld 460
Email: jessica.hassel@med.uni-heidelberg.de Dermatoonkologie
Heidelberg, 69120
Germany
9931
Approved v 1.0 930081508 1.0
CA209-037-0070* Kahler, Katharina, MD Universitaetsklinikum 1
Schleswig-Holstein
Grewe, Lena, MD (Office)
Hauptmann, Nora, MD Klinik Fur Dermatologie Venerologie
Hauschild, Axel, MD Und Allergologie
Kornek, Thomas, MD Schittenhelmstrasse 7
Schafer, Shirley, MD Kiel, D-24105
Germany
(P) +4904315972483
(F) +4904315972482 Universitaetsklinikum
Schleswig-Holstein
Email: kckaehler@yahoo.de (Pt Tx Ctr - Hosp/Med Ctr)
Klinik Fur Dermatologie Venerologie
Und Allergologie
Schittenhelmstrasse 7
Kiel, D-24105
Germany
CA209-037-0071* Krackhardt, Angela, MD Klinikum Rechts Der Isar Der Tu 10

Munchen
Abbrederis, Kathrin, MD (Office)
Belloni, Benedetta, MD Ismaninger Str 22
Esmaty, Alexander, MD Munich, 81675
Hein, Rueediger, MD, PhD Germany
Hoegner, Marion, MD
Weyrauch, Julia, MD Klinikum Rechts Der Isar Der Tu
Munchen
(F) +498941404878 III Medizinische Klinik
Ismaninger Str 22
Email: angela.krackhardt@lrz.tu-muenchen.de Munich, 81675
Germany
9932
Approved v 1.0 930081508 1.0
CA209-037-0072* Schadendorf, Dirk, MD, PhD Universitaetsklinikum Essen 11
(Office)
Cosgarea, Ioana, MD Klinik Fur Dermatologie
Freise-Vaubel, Julia M, MD Hufelandstrasse 55
Hermes, Isabel, MD Essen, 45122
Hohaus, Katja, MD Germany
Rompoti, Natalia, MD
Schilling, Bastian, MD Universitaetsklinikum Essen
Zimmer, Lisa, MD (Pt Tx Ctr - Hosp/Med Ctr)
Klinik Fur Dermatologie
(P) +492017230 Hufelandstrasse 55
(F) +492017230 Essen, 45122
Germany
Email: dirk.schadendorf@uk-essen.de
CA209-037-0073* Hoeller, Christoph, MD Medizinische Universitaet Wien/AKH 11

(Office)
Cicha, Astrid, MD Ebene 7J, Waehringer Guertel 18-20
Harmankaya, Kaan, MD Abteilung Fuer Allgemeine
Schicher, Nikolaus, MD Dermatologie
Schindler, Katja, MD Universitaetsklinik Fuer Dermatologie
Stepan, Andreas, MD Wien, A-1090
Torzicky, Martin, MD Austria
Wimmer, Nicole Gisela, MD
Medizinische Universitaet Wien/AKH
(F) +431404000 Ebene 7J, Waehringer Guertel 18-20
Abteilung Fuer Allgemeine
Email: christoph.hoeller@meduniwien.ac.at Dermatologie
Universitaetsklinik Fuer Dermatologie
Wien, A-1090
Austria
9933
Approved v 1.0 930081508 1.0
CA209-037-0074* Schmuth, Matthias, MD Med. Universitaet Innsbruck 0
(Office)
Bodenberger, Maresa, MD Dermatologie U. Venerologie
Moser-Oberthaler, Sabine, MD Anichstrasse 35
Mueller, Hansgeorg, MD Innsbruck, 6020
Nguyen, Van Anh, MD Austria
Stueckler, Christa, DR
Weinlich, Georg, MD Med. Universitaet Innsbruck
(P) +4351250424801 Dermatologie U. Venerologie
(F) +4351250425267 Anichstrasse 35
Innsbruck, 6020
Email: matthias.schmuth@i-med.ac.at Austria
CA209-037-0075* Dummer, Reinhard, MD Universitatsspital Zurich (Office) 3

Dermatologische Klinik
Galliker, Nadja, MD Gloriastr. 3
Goldinger, Simone M., MD Zurich, 8091
Naegeli, Mirjam, MD Switzerland
Stieger, Pascale, MD
Ziegler, Maya, MD Universitatsspital Zurich
(P) +41442551111 Dermatologische Klinik
(F) +41442558988 Gloriastr. 31
Zurich, 8091
Email: reinhard.dummer@usz.ch Switzerland
9934
Approved v 1.0 930081508 1.0
CA209-037-0076* Romano, Emanuela, MD Centre Hospitalier Universitaire Vaudois 4
(Office)
Michielin, Olivier, MD, PhD 46 Rue Du Bugnon
Centre D'oncologie
(P) +41213140185 Multidisciplinaire
(F) +41213144020 Lausanne, 1011
Switzerland
Email: emanuela.romano@chuv.ch
Centre Hospitalier Universitaire Vaudois
46 Rue Du Bugnon
Centre D'oncologie
Multidisciplinaire
Lausanne, 1011
Switzerland
CA209-037-0077* Gutzmer, Ralf, MD Medizinische Hochschule Hannover 16

(Office)
AlGhazal, Philipp, MD Klinik für Dermatologie
Alter, Mareike, MD OE 6600
Asper, Hiba, MD Hannover, 30625
Blasig, Hanna, MD Germany
Degen, Annette, MD
Koop, Anika, MD Medizinische Hochschule Hannover
Krengel, Sina, MD (Pt Tx Ctr - Hosp/Med Ctr)
Satzger, Imke, MD Klinik F .dermato-, Allergo-, Und
Tolk, Henrike, MD Venerologie
Hauttumorzentrum
(P) +495115323000 Ricklinger Strasse 5
(F) +495115329358 Hannover, 30449
Germany
Email: gutzmer.ralf@mh-hannover.de
9935
Approved v 1.0 930081508 1.0
CA209-037-0079* Soetekouw, Patricia, MD University Hospital Maastricht 0
(Office)
Essers-Aarts, Maureen, MD Depart of Internal Medicine
Hoeben, Ann, MD, PhD Division of Med Oncolgy
Jansen, Robertus, MD P. Debyelaan 25,
Lalisang, Roy I, MD Maastricht, 6229 HX
Tjan-Heijnen, Vivianne Christine Gerarda, MD Netherlands
Vincent, Jeroen, MD
Vriens, Ingeborg, MD University Hospital Maastricht
de Vos-Geelen, Judith, MD (Pt Tx Ctr - Hosp/Med Ctr)
Department of Internal Medicine
Division of Med Oncology
(P) +31433874696 P. Debyelaan 25
(F) +31433874692 Maastricht, 6229 HX,
Netherlands
Email: p.soetekouw@mumc.nl
CA209-037-0080* Arance, Ana, MD Hospital Clinic I Provincial 2

(Office)
Gaba, Lydia, MD Serv. Oncologia Esc. 2 Planta. 5
Victoria, Ivan, MD Villarroel, 170
Barcelona, 08036
(P) +34932275400 Spain
(F) +34934514439
Email: amarance@clinic.ub.es Hospital Clinic I Provincial

Serv. Oncologia Esc. 2 Planta. 5
Villarroel, 170
Barcelona, 08036
Spain
9936
Approved v 1.0 930081508 1.0
CA209-037-0081* Berrocal, Alfonso, MD Hospital General Univ De Valencia 1
(Office)
Palomar, Virginia, MD Avda. Tres Cruces,2
Umanzor, Gerardo, MD Pabellon A Planta 1-Seminario
Serv. Oncologia Medica
(P) +34961972141 Valencia, 46014
(F) +34961972085 Spain
Email: berrocal_alf@gva.es Hospital General Univ De Valencia

Servicio De Oncologia
Avda. Tres Cruces, S/N
Valencia, 46014
Spain
Hospital General Univ De Valencia

Pabellon A 1 Planta (seminario)
Serv. Oncologia Medica
Avda. Tres Cruces, 2
Valencia, Valencia, 46014
Spain
9937
Approved v 1.0 930081508 1.0
CA209-037-0082* Lopez-Martin, Jose A, MD, PhD Hospital Universitario 12 de Octubre 3
(Office)
Adeva, Jorge, MD Oncología Medica (UFTO)
Calvo, Aitana, MD Edificio Maternidad, Pl. 2
Parrilla, Lucia, MD Madrid, 28041
Spain
(P) +34913908000
Hospital Universitario 12 de Octubre
(F) +34914695775
Email: jalopezmartin@gmail.com Oncología Medica (UFTO)
Edificio Maternidad, Pl. 2
Madrid, 28041
Spain
CA209-037-0083* Martin Algarra, Salvador, MD Clinica Universitaria De Navarra 3

(Office)
Fernandez De Sanmamed, Miguel, MD 8ª Plta 5ª Fase, Despachos Oncología
Gurpide, Alfonso, MD Avda. Pio XII 36
Pamplona, 31192
(P) +34948286397 Spain
(F) +34948296500
Clinica Universitaria De Navarra
Email: smalgarra@unav.es (Pt Tx Ctr - Med Office/Clinic)
8ª Plta 5ª Fase, Despachos Oncología
Avda. Pio XII 36
Pamplona, 31192
Spain
9938
Approved v 1.0 930081508 1.0
CA209-037-0084* Ochoa De Olza, Maria, MD Instituto Catalan De Oncologia 1
(Office)
Jove Casulleras, Maria Avda. Gran Via De L'hospitalet 199-203
Jimenez-Colomo, Laura Hospitalet
Barcelona, 08908
Spain
Instituto Catalan De Oncologia

(F) +34932607801 Avda. Gran Via De L'hospitalet 199-203
Hospitalet
Email: mochoa@iconcologia.nety Barcelona, 08908
Spain
CA209-037-0085* Mohr, Peter, MD Elbe Klinikum Buxtehude 8

(Office)
Bluhm, Leonie, MD Am Krankenhaus 1
Dietrich, Vanessa, MD Buxtehude, 21614
Durda, Johanna, MD Germany
Finkeldey, Florence
Jaeger-Booth, Iris, MD Elbe Klinikum Buxtehude
Schinagl, Heidemarie (Pt Tx Ctr - Hosp/Med Ctr)
Dermatologisches Zentrum
(P) +4941617036212 Am Krankenhaus 1
(F) +4941617036445 Buxtehude, 21614
Germany
Email: peter.mohr@elbekliniken.de
9939
Approved v 1.0 930081508 1.0
CA209-037-0086 Hodi, F. Stephen, MD Dana Farber Cancer Institute 3
(Office)
Beeler, Maureen, RN 450 Brookline Ave.
Bhatt, Rupal S., MD Boston, MA 02215
Bowers, Mary Ellen, RN USA
Buchbinder, Elizabeth I, MD
Cho, Daniel C., MD Massachusetts General Hospital
Davis, Meredith, PA-C (Pt Tx Ctr - Hosp/Med Ctr)
Donahue, Hilary, MD 55 Fruit Street
Fadden, Riley M., NP Boston, MA 02215
Flaherty, Keith T, MD USA
Haq, Rizwan, MD
Ibrahim, Nageatte, MD Dana-Farber Cancer Institute
Kata, Caryn, RN (Pt Tx Ctr - Hosp/Med Ctr)
Kelley, Kristina, RN 450 Brookline Avenue
Lawrence, Donald, MD Boston, MA 0221
Lee, Mee-Young, NP USA
Livengood, Amanda J, RN
Luke, Jason, MD Dana-Farber Cancer Institute
Marujo, Rose, RN (Pt Tx Ctr - Hosp/Med Ctr)
McDermott, David, MD 450 Brookline Ave.
Mier, James, MD Pharmacy - Yawkey Fl 5th
Ott, Patrick, MD Boston, MA 02215
Renzi, Sharon, RN USA
Rubin, Krista, RN
Seery, Virginia J, NP
Sullivan, Ryan, MD Brigham & Women'S Hospital
Wood, Valerie J, RN (Pt Tx Ctr - Hosp/Med Ctr)
75 Francis St.
Boston, MA 02215
(P) 6176323786 USA
(F) 6176324301
Beth Israel Deaconess Medical Center
Email: (Pt Tx Ctr - Hosp/Med Ctr)
Email: stephen_hodi@dfci.harvard.edu 330 Brookline Ave
Boston, MA 02215
USA
9940
Approved v 1.0 930081508 1.0
CA209-037-0086 Massachusetts General Hospital
Hodi, F. Stephen, MD (Pt Tx Ctr - Hosp/Med Ctr)
(Cont’d) 32 Fruit St.
Pharmacy Yawkey 8
Boston, MA 02114
USA
CA209-037-0087* Kaufmann, Roland, MD Klinikum Der Johann Wolfgang 3

Goethe-Universitat
Clouth, Aline, MD (Office)
Gieding, Christine, MD Theodor-stern-kai 7
Meissner, Markus, MD Frankfurt Am Main, 60590
Messerschmidt, Anneli Katharina, MD Germany
Pinter, Andreas, MD
Schlosser, Rhea, MD Klinikum Der Johann Wolfgang
Schultheis, Katharina, MD Goethe-Universitat
(P) +496963016090 Theodor-stern-kai 7
(F) +496963014464 Frankfurt Am Main, 60590
Germany
Email: kaufmann@em.uni-frankfurt.de
9941
Approved v 1.0 930081508 1.0
CA209-037-0089* Schmerling, Rafael Aron, MD Real E Benemerita Associacao 4
Portuguesa De Beneficencia
Almeida Thiago, MD (Office)
Brandao, Erika Rua Martiniano De Carvalho, 951
Buzaid, Antonio Carlos, MD Bela Vista
Carvalho, Ricardo S, MD Sao Paulo, Sao Paulo, 01323-900
Costa, Marcos Andre Brazil
De Padua, Fernando
Kawamura, Carolina, MD Real E Benemerita Associacao
Maluf, Fernando Portuguesa De Beneficencia
Meirelles, Melissa, DR (Pt Tx Ctr - Hosp/Med Ctr)
Pimenta, Juliana, DR Rua Maritiniano De Carvalho,965
Schutz, Fabio Augusto Barros, PhD Bela Vista
Yamada, Camilla A. F. Sao Paulo, Sao Paulo, 01321-001
Brazil
(P) +551135051140
(F) +551135056614 Real E Benemerita Associacao
Portuguesa De Beneficencia
Email: rafael.schmerling@hospitalsjose.org.br (Pt Tx Ctr - Hosp/Med Ctr)
Rua Maestro Cardim, 769
Paraiso
Sao Paulo, Sao Paulo, 01323-900
Brazil
9942
Approved v 1.0 930081508 1.0
CA209-037-0090* Azevedo, Sergio Jobim, MD, PhD Hospital De Clinicas De Porto Alegre 4
(Office)
Casarotto Fernanda Cano, MD Ramiro Barcelos, 2350
Gastal, Gustavo Predio 21 /cpc, Sala 21502
Liedke, Pedro Rubini Bom Fim
Pereira, Rodrigo Perez, MD Porto Alegre, Rio Grande Do Sul
Schmidt, Luis Felipe Carissimi, MD 90035-903
Seewald, Rafael, MD Brazil
(P) +555133313834 Hospital De Clinicas De Porto Alegre

Bom Fim
Email: sazevedo@hcpa.ufrgs.br Porto Alegre, Rio Grande Do Sul
90035-903
Brazil
CA209-037-0091* Melo, Andreia Cristina De, MD Instituto Nacional De Cancer 1

(Office)
Dias, Mariane, MD Rua Equador 831
Garces, Alvaro, MD 3 andar
Mendes, Gelcio Rio de Janeiro, Rio de Janeiro 20220-410
Brazil
(P) +552125066000 Instituto Nacional De Cancer

Rua Equador 831
3 andar
Email: melo.andreia@uol.com.br Rio de Janeiro, Rio de Janeiro 20220-410
Brazil
9943
Approved v 1.0 930081508 1.0
CA209-037-0092* Lotem, Michal, MD Hadassah Hebrew University Hospital 1
(Office)
Frank, Stephen Jay, MD Sharett Institue Of Oncology
Merims, Sharon, MD Jerusalem, 71908
Sonnenblick, Amir, MD Israel
Tahover, Ester, MD
Hadassah Hebrew University Hospital
(F) +97226778841 Sharett Institue Of Oncology
Jerusalem, 71908
Email: mlotem@hadassah.org.il Israel
CA209-037-0093* Schachter, Jacob, MD Sheba Medical Center 3

(Office)
Ben-Ami, Eytan A, MD Ella Institute
Markel, Gal, MD Oncology Unit
Shapira Frommer, Ronnie, MD Tel Hashomer
Ramat Gan, 52621
(P) +97235305201 Israel
(F) +97235305201
Sheba Medical Center
Email: jacob.schachter@sheba.health.gov.il (Pt Tx Ctr - Hosp/Med Ctr)
Ella Institute
Oncology Unit
Tel Hashomer
Ramat Gan, 52621
Israel
9944
Approved v 1.0 930081508 1.0
CA209-037-0095* Mortier, Laurent, MD Chru De Lille - Hopital Claude Huriez 3
(Office)
Bertrand, Marie, MD Service des Dermatologie
Desmedt, Eve, MD rue Michel Polonovski
Maire, Cyril, MD Lille Cedex, 59037
Vercambre-Darras, Sophie, MD France
(P) +33320445609 Chru De Lille - Hopital Claude Huriez(Pt

(F) +33320445564 Tx Ctr - Hosp/Med Ctr)
Service des Dermatologie
Email: laurent.mortier@chru-lille.fr rue Michel Polonovski
Lille Cedex, 59037
France
CA209-037-0096* D'Incan, Michel, MD, PhD Chu Estaing (Office) 0

Amarger, Stéphanie, MD 1, place Lucie et Raymond Aubrac
Mansard, Sandrine, DR Clermont Ferrand, 63003
Piech, Charlotte, MD France
(P) +33473750550 Chu Estaing

(F) +33473751992 Pt Tx Ctr - Hosp/Med Ctr)
Email: mdincan@chu-clermontferrand.fr 1, place Lucie et Raymond Aubrac
Clermont Ferrand, 63003
France
9945
Approved v 1.0 930081508 1.0
CA209-037-0097* Lacour, Jean-Philippe, MD, PhD C H U Hopital De L'Archet 2 0
(Office)
Giacchero, Damien, MD Service de Dermatologie
Montaudie, Henri 151 route Saint Antoine de Ginestiere
BP 3079
(P) +33492037777 Nice, 06200
(F) +33492039368 France
Email: lacour@unice.fr C H U Hopital De L'Archet 2

Service de Dermatologie
151 route Saint Antoine de Ginestiere
BP 3079
Nice, 06200
France
CA209-037-0098* Rodriguez, Juan Francisco, MD Hospital De Madrid, Norte Sanchinarro 1

(Office)
Garcia Donas, Jesus, MD Ona 10
Romero, Nuria Unidad de Tumores Ginecologicos
Genito-Urinarios
(P) +34917567876 Cancer de Piel
(F) +34917500439 Madrid, 28020
Spain
Email: jfrodriguez@hmhospitales.com
Hospital De Madrid, Norte Sanchinarro
Ona 10
Unidad de Tumores Ginecologicos
Genito-Urinarios
Cancer de Piel
Madrid, 28020
Spain
9946
Approved v 1.0 930081508 1.0
CA209-037-0099* Goeppner, Daniela, MD Universitaetsklinikum Magdeburg 2
(Office)
Bellutti, Michael, MD Leipziger Str. 44
Gollnick, Harald, MD Magdeburg, 39120
Papathemeli, Despoina, MD Germany
Schott, Regina, MD
Universitaetsklinikum Magdeburg
(F) +4939167113105 Leipziger Str. 44
Magdeburg, 39120
Email: daniela.goeppner@med.ovgu.de Germany
CA209-037-0100* Gesierich, Anja, MD Univ. Klinikum Wuerzburg 3

(Office)
Behle, Valeria, MD Josef Schneider Str 2
Buder, Kristina, MD Haus D8
Haferkamp, Sebastian, MD Wuerzburg, Bayern, 97080
Germany
(P) +4992120126135
(F) +4993120126736 Univ. Klinikum Wuerzburg
Email: gesierich_a@klinik.uni-wuerzburg.de Josef Schneider Str 2
Haus D8
Wuerzburg, Bayern, 97080
Germany
9947
Approved v 1.0 930081508 1.0
CA209-037-0101* Stein, Annette, MD Universitaetsklinikum Carl Gustav Carus 2
(Office)
Beissert, Stefan Carl Gustav Carus
Garzarolli, Marlene, MD Fetscherstrasse 74
Rauschenberg, Ricarda, DR Dresden, 01307
Viehweg, Antje Germany
(P) +493517965620 Universitaetsklinikum Carl Gustav Carus

Carl Gustav Carus
Email: annette.stein@uniklinikum-dresden.de Fetscherstrasse 74
Dresden, 01307
Germany
CA209-037-0102* Mandala, Mario, MD A.O. Papa Giovanni XXIII (Office) 2

UO Oncologa Medica
Merelli, Barbara, MD Piazza OMS 1
Bergamo, 24127
(P) +390352674710 Italy
(F) +390352674823
A.O. Papa Giovanni XXIII
Email: mmandala@hpg23.it (Pt Tx Ctr - Hosp/Med Ctr)
UO Oncologa Medica
Piazza OMS 1
Bergamo, 24127
Italy
9948
Approved v 1.0 930081508 1.0
CA209-037-0105 Amatruda, Thomas, MD Allina Health (Office) 2
Virginia Piper Cancer Institute
Anderson, Chara J, ANP 800 East 28th Street, Suite 602
Bloom, Stuart, MD Minneapolis, MN, 55407
Bosshardt, Laura, RN USA
Finnes, Laura, RN
Gesme, Dean H, MD Minnesota Oncology Hematology, P.A.
Houselog, Kathryn Lynn, CNP (Pt Tx Ctr - Med Office/Clinic)
Larson, Tim G, MD 910 E 26th St. Ste 200
Leach, Joseph Ward, MD Minneapolis, MN, 55404
Seng, John E, MD USA
Tsai, Michaela, MD
Underhill, Jacquelyn, RN Allina Health
Wojchik, Alicia J, CNP (Pt Tx Ctr - Med Office/Clinic)
Yilek, Amy K, CNP Virginia Piper Cancer Institute
800 East 28th Street, Suite 602
(P) 6128634633 Minneapolis, MN, 55407
(F) 6128633883 USA
Email: thomas.amatruda@usoncology.com Abbott Northwestern Hospital

800 East 28th Street
Pharmacy Department 11321
Minneapolis, MN, 55407
USA
Abbott Northwestern Hospital

800 E 28th St.
Minneapolis, MN, 55407
USA
9949
Approved v 1.0 930081508 1.0
CA209-037-0110* Terheyden, Patrick, MD Medizinische Universitaet Zu Luebeck 4
(Office)
Anguen, Ozan, MD Ratzeburger Allee 160
Fischer, Tobias, MD Luebeck, 23538
Frambach, Yvonne, MD Germany
Moeckel, Nicole
Mohr, Martin, MD Medizinische Universitaet Zu Luebeck
(P) +494515002056 Ratzeburger Allee 160
(F) +494515005024 Luebeck, 23538
Germany
Email: patrick.terheyden@uk-sh.de
*denotes non-IND site
9950
Approved v 1.0 930081508 1.0

603v16n04 90399541mmc1

Uploaded by

Document Information

Original Description:

Original Title

Copyright

Available Formats

Share this document

Share or Embed Document

Sharing Options

Did you find this document useful?

Is this content inappropriate?

Copyright:

Available Formats

603v16n04 90399541mmc1

Uploaded by

Copyright:

Available Formats

Supplementary appendix

Complete response 4 (3·3) 0 (0) 0 (0)

Partial response 34 (28·3) 0 (0) 5 (17·9)

Stable disease 28 (23·3) 6 (31·6) 10 (35·7)

Progressive disease 42 (35·0) 8 (42·1) 7 (25·0)

Unable to determine† 12 (10·0) 5 (26·3) 6 (21·4)

ORR difference to nivolumab group,

Total patients with an event, n (%) 34 (75.6) 11 (24.4) 0 47 (82.5) 21 (36.8) 0

Alopecia 1 (2.2) 0 0 27 (47.4) 0 0

Nausea 15 (33.3) 1 (2.2) 0 23 (40.4) 1 (1.8) 0

Fatigue 14 (31.1) 0 0 21 (36.8) 4 (7.0) 0

Anemia 6 (13.3) 1 (2.2) 0 17 (29.8) 4 (7.0) 0

Neutropenia 6 (13.3) 3 (6.7) 0 13 (22.8) 11 (19.3) 0

Decreased appetite 10 (22.2) 0 0 6 (10.5) 0 0

Vomiting 9 (20.0) 1 (2.2) 0 11 (19.3) 1 (1.8) 0

Diarrhea 4 (8.9) 1 (2.2) 0 11 (19.3) 1 (1.8) 0

Arthralgia 1 (2.2) 0 0 11 (19.3) 1 (1.8) 0

Constipation 4 (8.9) 0 0 10 (17.5) 1 (1.8) 0

Thrombocytopenia 1 (2.2) 1 (2.2) 0 9 (15.8) 5 (8.8) 0

Peripheral neuropathy 0 0 0 9 (15.8) 1 (1.8) 0

WBC count decreased 2 (4.4) 0 0 6 (10.5) 1 (1.8) 0

3) Age and Reproductive Status

Women of Childbearing Potential

Appendix 1.5 List and Description of Investigators for Study CA209-037

CA209-037-0005* Hospers, G. A. P, MD Universitair Medisch Centrum 5

(P) +31503616161 Universitair Medisch Centrum

CA209-037-0007* Haanen, John, PhD Antoni Van Leeuwenhoek Ziekenhuis 5

(P) +31205122569 Antoni Van Leeuwenhoek Ziekenhuis

(P) +442380796164 Southampton University Hospital NHS

CA209-037-0009* Lorigan, Paul, MD The Christie NHS Foundation Trust 13

(P) +01614463000 The Christie NHS Foundation Trust

CA209-037-0011* Plummer, Elizabeth, MD Freeman Hospital 5

CA209-037-0013* Middleton, Mark, MD Churchill Hospital (Office) 9

CA209-037-0014 Amin, Asim, MD, PhD Levine Cancer Institute (Office) 5

(P) 9804425300 Carolinas Medical Center

CA209-037-0015 Grossmann, Kenneth, MD, PhD Huntsman Cancer Institute (Office) 13

(P) 8015874573 Huntsman Cancer Institute

Huntsman Cancer Hospital

CA209-037-0017 Lawson, David H., MD Winship Cancer Institute (Office) 7

Emory University Hospital Midtown

The Emory Clinic

The Emory Clinic

CA209-037-0018 Gonzalez, Rene, MD University Of Colorado Cancer Center 0

Anschutz Cancer Pavilion

CA209-037-0019 Daud, Adil, MD UCSF Comprehensive Cancer Center 11

(P) 4153537052 UCSF Medical Center at Mount Zion

CA209-037-0020 Hodi, F. Stephen, MD Dana-Farber Cancer Institute (Office) 6

CA209-037-0020 Beth Israel Deaconess Medical Center

CA209-037-0021 Pavlick, Anna Catherine, DO NYU Clinical Cancer Center (Office) 3

New York University Langone Medical

New York University Clinical Cancer

CA209-037-0022 Sosman, Jeffrey A, MD Vanderbilt-Ingram Cancer Center 11

Henry-Joyce Cancer Clinic

CA209-037-0023 Thomas, Sajeve, MD Orlando Health, Inc (Office) 9

Email: sajeve.thomas@orlandohealth.com Orlando Regional Medical Center

Orlando Health, Inc

Orlando Health, Inc

MD Anderson Cancer Center Orlando (Pt

Md Anderson Cancer Center Orlando

(P) 3102940438 The Angeles Clinic & Research Institute

The Angeles Clinic & Research Institute

Email: jinfante@tnonc.com Sarah Cannon Research Institute